The Big Hurt: Second Major Fibromyalgia Drug in a Year Fails
It wasn’t supposed to go this way. Daiichi Sankyo bet big, big money that it’s safer, more effective version of Lyrica (pregabalin) called mirogabalin was going to be the next big thing in fibromaylgia (FM). It was so confident that it embarked on a...
Top Fibromyalgia Drug Tanks: Four Other Drugs On Way
Tomnya had everything going for it; a novel approach to pain and good Phase II trial results, but Tonix’s reformulation of Flexeril that was expected to help with both sleep and pain tanked in its critical Phase III trial. Check out what happened with it, and...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
